No phaseRecruiting
Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People (NMNAGING)
Quzhou Population Cohort Research Project (Aging Related Research: Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People)
- Sponsor
- People's Hospital of Quzhou (Academic or other)
- Enrolment
- 240 planned
- Conditions
- Aging; NMN
- Interventions
- NMN; placebo
- Ages
- adults, older adults
- Registry
- NCT06592859
From the registry
This study is a single-center, randomized, double-blind, placebo-controlled clinical trial investigating a pharmacological intervention for aging. Its primary objective is to evaluate the efficacy of NMN while ensuring the safety of oral administration, with the aim of identifying effective strategies to delay aging and improve the quality of life in the elderly population. The main outcomes of this study are to characterize the patterns of NMN efficacy across different populations and to identify sensitive biomarkers that reflect responsiveness to the intervention.
Primary outcomes
- Comprehensive evaluation of NMN in reducing biological age